A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Conditions
Severe Hemophilia A
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center, Los Angeles, California, United States
Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States
ECU Health Medical Center, Greenville, North Carolina, United States
Nirmal Hospital Pvt Ltd., Surat, Gujarat, India
K J Somaiya Hospital & Research Centre, Mumbai, Maharashtra, India
Ege University Faculty of Medicine Dean's Office, Bornova, İzmir, Turkey (Türkiye)
Istanbul Universitesi Tıp Fakultesi Onkoloji Enstitusu, Fatih, İ̇stanbul, Turkey (Türkiye)
Study leads
Pfizer CT.gov Call Center
Study Director
Pfizer